FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137326512> ?p ?o ?g. }

• W2137326512 endingPage "596" @default.
• W2137326512 startingPage "590" @default.
• W2137326512 abstract "Effective treatment with factor IX (FIX) requires a thorough consideration of the properties of the concentrate to be used as replacement therapy, to date, the only available treatment for haemophilia B. The aim of the study was to determine the pharmacokinetics, clinical efficacy and safety in routine clinical use of AlphaNine(®) , a high-purity human FIX concentrate. This open, single-arm, multicentre, non-randomized trial included 25 subjects (age ≥ 12) with moderate/severe haemophilia B. Pharmacokinetics was assessed at baseline and after a 6-month follow-up. The degree of haemostasis control achieved was evaluated during a 12-month follow-up. Safety was evaluated in terms of tolerance, thrombogenicity, immunogenicity and viral safety. Mean recovery was 1.01 ± 0.19 IU dL(-1) per IU kg(-1) at baseline and 1.23 ± 0.34 IU dL(-1) per IU kg(-1) 6 months later. Terminal half-life was 34.5 ± 6.2 h and 33.7 ± 5.4 h, respectively. Ratios of each parameter between the two pharmacokinetic studies were all close to 1. A total of 1,576,890 IU AlphaNine(®) were administered in 889 infusions (mean dose per infusion: 1774 IU; 3.2 infusions per month per patient). The main reasons for infusion were mild/moderate bleeding (62.3%) and prophylaxis (20.5% continuous, 15.6% intermittent). Overall, 93.0% of the efficacy assessments were rated as excellent/good and 88.8% of bleedings resolved after the first infusion. Twenty-one adverse events were reported in eight patients, none of which was considered related to the study medication. AlphaNine(®) showed a pharmacokinetic profile in agreement with that of other plasma-derived FIX concentrates and provides safe and clinically effective substitution therapy for patients with haemophilia B." @default.
• W2137326512 created "2016-06-24" @default.
• W2137326512 creator A5002202831 @default.
• W2137326512 creator A5002790287 @default.
• W2137326512 creator A5003551278 @default.
• W2137326512 creator A5008391074 @default.
• W2137326512 creator A5017718090 @default.
• W2137326512 creator A5019468761 @default.
• W2137326512 creator A5030441869 @default.
• W2137326512 creator A5054363370 @default.
• W2137326512 creator A5060103925 @default.
• W2137326512 creator A5071752621 @default.
• W2137326512 date "2011-02-07" @default.
• W2137326512 modified "2023-10-08" @default.
• W2137326512 title "A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high-purity factor IX concentrate, in patients with severe haemophilia B" @default.
• W2137326512 cites W102089073 @default.
• W2137326512 cites W1969941406 @default.
• W2137326512 cites W1975184789 @default.
• W2137326512 cites W1978184135 @default.
• W2137326512 cites W1984929231 @default.
• W2137326512 cites W1986601719 @default.
• W2137326512 cites W1988890548 @default.
• W2137326512 cites W1990335353 @default.
• W2137326512 cites W2001037879 @default.
• W2137326512 cites W2017233069 @default.
• W2137326512 cites W2052198317 @default.
• W2137326512 cites W2066304010 @default.
• W2137326512 cites W2082072397 @default.
• W2137326512 cites W2085100283 @default.
• W2137326512 cites W2095006833 @default.
• W2137326512 cites W2095828288 @default.
• W2137326512 cites W2103499505 @default.
• W2137326512 cites W2122398779 @default.
• W2137326512 cites W2135468468 @default.
• W2137326512 cites W2140499177 @default.
• W2137326512 cites W2166182759 @default.
• W2137326512 cites W2313774959 @default.
• W2137326512 cites W2414166825 @default.
• W2137326512 doi "https://doi.org/10.1111/j.1365-2516.2010.02470.x" @default.
• W2137326512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21299747" @default.
• W2137326512 hasPublicationYear "2011" @default.
• W2137326512 type Work @default.
• W2137326512 sameAs 2137326512 @default.
• W2137326512 citedByCount "20" @default.
• W2137326512 countsByYear W21373265122012 @default.
• W2137326512 countsByYear W21373265122013 @default.
• W2137326512 countsByYear W21373265122014 @default.
• W2137326512 countsByYear W21373265122016 @default.
• W2137326512 countsByYear W21373265122017 @default.
• W2137326512 countsByYear W21373265122018 @default.
• W2137326512 countsByYear W21373265122020 @default.
• W2137326512 crossrefType "journal-article" @default.
• W2137326512 hasAuthorship W2137326512A5002202831 @default.
• W2137326512 hasAuthorship W2137326512A5002790287 @default.
• W2137326512 hasAuthorship W2137326512A5003551278 @default.
• W2137326512 hasAuthorship W2137326512A5008391074 @default.
• W2137326512 hasAuthorship W2137326512A5017718090 @default.
• W2137326512 hasAuthorship W2137326512A5019468761 @default.
• W2137326512 hasAuthorship W2137326512A5030441869 @default.
• W2137326512 hasAuthorship W2137326512A5054363370 @default.
• W2137326512 hasAuthorship W2137326512A5060103925 @default.
• W2137326512 hasAuthorship W2137326512A5071752621 @default.
• W2137326512 hasConcept C112705442 @default.
• W2137326512 hasConcept C126322002 @default.
• W2137326512 hasConcept C141071460 @default.
• W2137326512 hasConcept C197934379 @default.
• W2137326512 hasConcept C2777081929 @default.
• W2137326512 hasConcept C2777232031 @default.
• W2137326512 hasConcept C2778385053 @default.
• W2137326512 hasConcept C2781221834 @default.
• W2137326512 hasConcept C535046627 @default.
• W2137326512 hasConcept C71924100 @default.
• W2137326512 hasConceptScore W2137326512C112705442 @default.
• W2137326512 hasConceptScore W2137326512C126322002 @default.
• W2137326512 hasConceptScore W2137326512C141071460 @default.
• W2137326512 hasConceptScore W2137326512C197934379 @default.
• W2137326512 hasConceptScore W2137326512C2777081929 @default.
• W2137326512 hasConceptScore W2137326512C2777232031 @default.
• W2137326512 hasConceptScore W2137326512C2778385053 @default.
• W2137326512 hasConceptScore W2137326512C2781221834 @default.
• W2137326512 hasConceptScore W2137326512C535046627 @default.
• W2137326512 hasConceptScore W2137326512C71924100 @default.
• W2137326512 hasIssue "4" @default.
• W2137326512 hasLocation W21373265121 @default.
• W2137326512 hasLocation W21373265122 @default.
• W2137326512 hasOpenAccess W2137326512 @default.
• W2137326512 hasPrimaryLocation W21373265121 @default.
• W2137326512 hasRelatedWork W1733829367 @default.
• W2137326512 hasRelatedWork W1978184135 @default.
• W2137326512 hasRelatedWork W1978722901 @default.
• W2137326512 hasRelatedWork W1986601719 @default.
• W2137326512 hasRelatedWork W1988846258 @default.
• W2137326512 hasRelatedWork W1990335353 @default.
• W2137326512 hasRelatedWork W2003504255 @default.
• W2137326512 hasRelatedWork W2095006833 @default.
• W2137326512 hasRelatedWork W2139378749 @default.
• W2137326512 hasRelatedWork W3003294804 @default.
• W2137326512 hasVolume "17" @default.

• next